Emcure Pharmaceuticals Limited (NSE:EMCURE)

India · Delayed Price · Currency is INR

1,705.20

+9.20 (0.54%)

Jun 1, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011
Pharmaceuticals	92.04B	78.96B	66.58B	59.86B	58.55B
Pharmaceuticals Growth	16.56%	18.59%	11.23%	2.23%	16.33%
Total	92.04B	78.96B	66.58B	59.86B	58.55B
Total Growth	16.56%	18.59%	11.23%	2.23%	16.33%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011
India	40.27B	36.59B	32.15B	31.82B	32.05B
India Growth	10.05%	13.82%	1.04%	-0.71%	27.67%
EM	18.40B	-	-	-	-
EU	18.50B	-	-	-	-
CA	14.87B	-	-	-	-
ROW	-	14.15B	10.92B	8.87B	10.74B
ROW Growth	-	29.55%	23.06%	-17.42%	-4.85%
Europe	-	15.25B	14.24B	11.87B	8.97B
Europe Growth	-	7.16%	19.90%	32.39%	21.47%
North America	-	12.97B	9.28B	7.29B	6.79B
North America Growth	-	39.75%	27.21%	7.35%	3.60%
Total	92.04B	78.96B	66.58B	59.86B	58.55B
Total Growth	16.57%	18.59%	11.23%	2.23%	16.33%

Source: S&P Global Market Intelligence.